Cancer vaccine News
Scientists identified a molecule called Diprovocim that can be added to a cancer vaccine to boost the immune system's ability to fight skin cancer.
A clinical trial was launched in January to test the effect of the treatment in humans with lymphoma, cancer of the lymphatic system.
Loading...